Publications

Search our bibliography using the filters on the right-hand side.

Displaying 1 through 50 of 186 publications.

Garcia R, Benet M, Arnau C, Cobo E. Efficiency of the cross-over design: an empirical estimation. Stat Med. 2004 Dec 30;23(24):3773-80. doi: 10.1002/sim.2072.

Kaye JA, Jick H. Epidemiology of lower limb fractures in general practice in the United Kingdom. Inj Prev. 2004 Dec;10(6):368-74.

Baker D, Brown Z, Hollier LM, Wendel GD, Hulme L, Griffiths DA, Mauskopf J. Cost-effectiveness of herpes simplex virus type 2 serologic testing and antiviral therapy in pregnancy. Am J Obstet Gynecol. 2004 Dec 1;191(6):2074-84.

Skriver MV, Pedersen L, Stang P, Lund L, Rothman KJ, Sorensen HT. The month of birth does not affect the risk of hypospadias. Eur J Epidemiol. 2004 Dec 1;19(12):1135-6.

Berchuck A, Schildkraut JM, Wenham RM, Calingaert B, Ali S, Henriott A, Halabi S, Rodriguez GC, Gertig D, Purdie DM, Kelemen L, Spurdle AB, Marks J, Chenevix-Trench G. Progesterone receptor promoter +331A polymorphism is associated with a reduced risk of endometrioid and clear cell ovarian cancers. Cancer Epidemiol Biomarkers Prev. 2004 Dec 1;13(12):2141-7.

Williams LK, Pladevall-Vila M, Xi H, Peterson EL, Joseph C, Lafata JE, Ownby DR, Johnson CC. Relationship between adherence to inhaled corticosteroids and poor outcomes among adults with asthma. J Allergy Clin Immunol Pract. 2004 Dec;114(6):1288-93.

Njue AI, Prichard RK. Genetic variability of glutamate-gated chloride channel genes in ivermectin-susceptible and -resistant strains of Cooperia oncophora. Parasitology. 2004 Dec 1;129(06):741-51.

Mannila MN, Silveira A, Hawe E, Eriksson P, Aillaud MF, Juhan-Vague I, Yudkin J, Margaglione M, di Minno G, Mussoni L, Tremoli E, Humphries S, Hamsten A, HIFMECH Study Group. Plasma fibrinogen concentration predicts the risk of myocardial infarction differently in various parts of Europe: effects of beta-fibrinogen genotype and environmental factors. The HIFMECH Study. Thromb Haemost. 2004 Dec;92(6):1240-9.

Pladevall-Vila M, Williams LK, Potts LA, Divine G, Xi H, Lafata JE. Clinical outcomes and adherence to medications measured by claims data in patients with diabetes. Diabetes Care. 2004 Dec;27(12):2800-5.

McKenna SP, Meads DM, Doward LC. Scaling properties of the Dermatology Life Quality Index (DLQI). Poster presented at the 2004 ISPOR 7th Annual European Congress; November 2004. Hamburg, Germany. [abstract] Value Health. 2004 Nov; 7(6):750-1.

von Scheele B, David K, Gaffney L, Niculescu L, Verburg KM. The total cost of treatment and the cost-effectiveness of valdecoxib vs diclofenac in the treatment of patients with osteoarthritis (OA) of the hip and/or knee. Poster presented at the 2004 ISPOR 7th Annual European Congress; October 24, 2004. [abstract] Value Health. 2004 Nov; 7(6):661.

Earnshaw SR, Beard SM, Gaffney L, Krishnan A, Hogue SL. The impact of premature discontinuation of antidepressant therapy in major depressive disorder in the UK. Poster presented at the 2004 ISPOR 7th Annual European Congress; October 24, 2004. [abstract] Value Health. 2004 Nov; 7(6):A779.

Alten RH, von Scheele B, Gaffney L, Maciver F, Niculescu L. Cost-effectiveness of valdecoxib compared to diclofenac in patients with rheumatoid arthiritis (RA) in the United Kingdom (UK) and Germany. Poster presented at the 2004 ISPOR 7th Annual European Congress; October 24, 2004. [abstract] Value Health. 2004 Nov; 7(6).

Bartosch WJ, Bray JW, Davis KL, Graver L, Schroeder D, Miller K. Variations in mental health and substance abuse service provider types between medicaid and state agencies in three states. Presented at the 132nd Annual Meeting of the American Public Health Association; November 2004.

Schmidt RA, Ackerman SJ, Newstead GM, Quam JP, Mordin MM, Anastassopoulos K, Nishikawa RM. Comparative feature analysis of computed radiography for mammography (CRM) soft copy display vs. crm hard copy film: an observer performance study. Poster presented at the 90th Scientific Assembly and Annual Meeting of the Radiology Society of North America; November 2004.

Sunyer J, Jarvis D, Pekkanen J, Chinn S, Janson C, Leynaert B, Luczynska C, Garcia-Esteban R, Burney P, Anto JM, European Community Respiratory Health Survey Study Group. Geographic variations in the effect of atopy on asthma in the European Community Respiratory Health Study. J Allergy Clin Immunol. 2004 Nov;114(5):1033-9. doi: 10.1016/j.jaci.2004.05.072

Meads DM, Doughty NJ, McKenna SP, Doward LC, Pepke-Zaba J. Disease specific versus generic outcome assessment in pulmonary hypertension. Poster presented at the 2004 ISPOR 7th Annual European Congress; November 2004. Hamburg, Germany. [abstract] Value Health. 2004 Nov; 7(6):701-2.

Meads DM, McKenna SP, Doughty NJ, Doward LC, Pepke-Zaba J. Validation of the pulmonary hypertension outcome review (CAMPHOR) questionnaire. Poster presented at the 2004 ISPOR 7th Annual European Congress; November 2004. Hamburg, Germany. [abstract] Value Health. 2004 Nov; 7(6):700-1.

Lucero MA, Mladsi D, Mauskopf J. Communicating the value: developing messages for payers. Presented at the 2004 ISPOR 7th Annual European Congress; October 24, 2004. Hamburg, Germany.

Carroll I, Thomas JB, Dykstra LA, Granger AL, Allen RM, Howard JL, Pollard GT, Aceto MD, Harris LS. Pharmacological properties of JDTic: a novel kappa-opioid receptor antagonist. Eur J Pharmacol. 2004 Oct 6;501(1-3):111-9.

Vickers AD, Mellor P, Brice R. Over-estimation in market simulations: an explanation and solution to the problem with particular reference to the pharmaceutical industry. Presented at the Eleventh Sawtooth Software Conference; October 6, 2004. San Diego, CA.

Barrows SM, Brown MT. Effect of valdecoxib on functional impairment, quality of life and patient satisfaction in migraine patients. Poster presented at the Annual Meeting of the American College of Nurse Practitioners; October 2004.

Cropper ML, Haile M, Lampietti J, Poulos C, Whittington D. The demand for a malaria vaccine: evidence from Ethiopia. J Dev Econ. 2004 Oct 1;75(1):303-18.

Ervin CM. The North Carolina collaborative stroke registry. Poster presented at the North Carolina Stroke Association Annual Convention; October 2004.

Brogan AJ, Mauskopf JA, Quattek K, Jordan J. Lower resource use of 908/ritonavir compared to nelfinavir may be explained by better tolerability. Poster presented at the 42nd Annual Meeting of the Infectious Disease Society of America; October 2004.

Mines D, Novelli L. The risk of first seizure associated with mefenamic acid in women of reproductive age. Poster presented at the 2004 20th International Conference on Pharmacoepidemiology; August 2004. Bordeaux, France. [abstract] Pharmacoepidemiol Drug Saf. 2004 Sep 23; 13(S1).

Mines DI, Novelli L. The risk of upper gastrointestinal tract bleeding associated with mefenamic acid in women of reproductive age. Poster presented at the 2004 20th ICPE International Conference on Pharmacoepidemiology & Therapeutic Risk Management; August 2004. Bordeaux, France. [abstract] Pharmacoepidemiol Drug Saf. 2004 Sep 23; 13(Suppl 1):S54-5. doi: 10.1002/pds.987

Gimeno V, Castellsague J, Maguire A, Eaton SC, McQuay LJ, Zhou X, Perez-Gutthann S. Gastrointestinal and cardiovascular characterization of users of valdecoxib and other cox-2 specific inhibitors. Presented at the 20th ICPE International Conference on Pharmacoepidemiology & Therapeutic Risk Management; August 22, 2004. Bordeaux, France. [abstract] Pharmacoepidemiol Drug Saf. 2004 Sep 23; 13(S1):S236.

Arana A, Arellano FM, Sánchez-Matienzo D, Perez-Gutthann S. Choosing the measure of relative proportional reporting in quantitative analyses of spontaneous reports. Presented at the 20th ICPE International Conference on Pharmacoepidemiology & Therapeutic Risk Management; August 22, 2004. Bordeaux, France. [abstract] Pharmacoepidemiol Drug Saf. 2004 Sep 23; 13(Suppl 1):S324.

Arana A, Rivero E, Egberts TCG. What do we show and who does so? An analysis of the abstracts presented at the 19th ICPE. Presented at the 20th ICPE International Conference on Pharmacoepidemiology & Therapeutic Risk Management; August 22, 2004. Bordeaux, France. [abstract] Pharmacoepidemiol Drug Saf. 2004 Sep 23; 13(Suppl 1):s330-1.

Maguire A, Arellano Felix M, Perez-Gutthann S, Arana A. Risk benefit modeling: the use of stochastic simulation for safety evaluations. Presented at the 20th ICPE International Conference on Pharmacoepidemiology & Therapeutic Risk Management; August 22, 2004. Bordeaux, France. [abstract] Pharmacoepidemiol Drug Saf. 2004 Sep 23; 13(Suppl 1):S272.

Johannes CB, Schneider GA, Walker AM, Viveash D, Wallis WJ. Increased incidence of lymphoma among patients with rheumatic diseases based on automated insurance claims information. Presented at the 20th ICPE International Conference on Pharmacoepidemiology & Therapeutic Risk Management; August 22, 2004. Bordeaux, France. [abstract] Pharmacoepidemiol Drug Saf. 2004 Sep 23; 13:S239.

Johannes CB, Schneider GA, Walker AM, Zhao S, Shibata A. Validation of a propensity score developed using claims data in controlling for health status of rheumatic disease patients initiating etanercept compared with other DMARDS. Presented at the 20th ICPE International Conference on Pharmacoepidemiology & Therapeutic Risk Management; August 22, 2004. Bordeaux, France. [abstract] Pharmacoepidemiol Drug Saf. 2004 Sep 23; 13(S1):S16.

Sanchez-Matienzo D, Castellsague J, Arana A. Effect of control of confounding in the estimation of the proportional reporting ratio. Presented at the 20th ICPE International Conference on Pharmacoepidemiology & Therapeutic Risk Management; August 22, 2004. Bordeaux, France. [abstract] Pharmacoepidemiol Drug Saf. 2004 Sep 23; 13(Suppl 1):S225-6.

Leufkens HG, Arana A. Pharmacoepidemiology adds to orphan drug development. Presented at the 20th ICPE International Conference on Pharmacoepidemiology & Therapeutic Risk Management; August 22, 2004. Bordeaux, France. [abstract] Pharmacoepidemiol Drug Saf. 2004 Sep 23; 13(Suppl 1):S256-7.

Andrews E, Dombeck M. The role of scientific evidence of risks and benefits in determining risk management policies for medications. Pharmacoepidemiol Drug Saf. 2004 Sep 1;13(9):599-608.

Fehnel SE, Bann CM, Hogue SL, Kwong WJ, Mahajan SS. The development and psychometric evaluation of the motivation and energy inventory (MEI). Qual Life Res. 2004 Sep 1;13(7):1321-36.

Harris DH, Bates JH, Cress R, Tabnak F, Wright WE. Stage of breast cancer diagnosis among medically underserved women in California receiving mammography through a state screening program. Cancer Causes Control. 2004 Sep;15(7):721-9.

Bradbury BD, Lash TL, Kaye JA, Jick SS. Tamoxifen and cataracts: a null association. Breast Cancer Res Treat. 2004 Sep;87(2):189-96.

Maguire A, Melero-Montes M, Saez-Lloret I, Varas-Lorenzo C, Perez-Gutthann S. Changes in hypokalemia and hyperkalemia between 1991 and 2000 in the US according to hypertensive status and treatment. Poster presented at the 20th ICPE International Conference on Pharmacoepidemiology & Therapeutic Risk Management; August 2004. Bordeaux, France. [abstract] Pharmacoepidemiol Drug Saf. 2004 Sep; 13:S303.

Knight C, Hind D, Brewer N, Abbott V. Rituximab (MabThera) for aggressive non-Hodgkin's lymphoma: systematic review and economic evaluation. Health Technol Assess. 2004 Sep;8(37):1-82.

Hahn EJ, Rayens MK, Chirila C, Riker CA, Paul TP, Warnick TA. Effectiveness of a quit and win contest with a low-income population. Prev Med. 2004 Sep 1;39(3):543-50.

Midkiff KD. An introduction to transact structured query language. Poster presented at the Bi-Annual Meeting of the Prostate, Lung, Colorectal, and Ovarian Cancer Screening Trial Steering Committee; September 2004. Santa Fe, NM.

Wright J, Bareford D, Wright C, Augustine G, Olley K, Musamadi L, Dhanda C, Knight C. Day case management of sickle pain: 3 years experience in a UK sickle cell unit. Br J Haematol. 2004 Sep;126(6):878-80.

Clarkson TB, Anthony MS, Cline JM, Lees CJ, Ederveen AG. Multisystem evaluations of the long-term effects of tibolone on postmenopausal monkeys. Maturitas. 2004 Aug 30;48(Suppl 1):24-9. doi: 10.1016/j.maturitas.2004.02.011

Johnson FR, Andrews EB. Using stated-preference methods to inform pharmaceutical risk management. Poster presented at the 20th ICPE International Conference on Pharmacoepidemiology & Therapeutic Risk Management; August 22, 2004. Bordeaux.

Andrews EB, Hollis KA, Miller D, Tennis P, Bennett L, Ameen VZ, Heath A, McSorley D, Cook SF. A patient follow-up survey program for lotronex (Alosetron HCL): accessing compliance with the risk management program. Poster presented at the 20th ICPE International Conference on Pharmacoepidemiology & Therapeutic Risk Management; August 22, 2004. Bordeaux.

Andrews EB, Cook SF, Miller DP, Walker AM, Avorn J, Gurwitz J, Tennis PS. Development and implementation of risk management program for lotronex (Alosetron HCL). Presented at the 20th ICPE International Conference on Pharmacoepidemiology & Therapeutic Risk Management; August 22, 2004. Bordeaux.

Eaton SC, Mangel AW, Hollis KA, Ameen VZ, Hamm LR, Andrews EB, Williams RL, Cook SF. Symptoms of diarrhea-predominant or alternating IBS: an exploratory analysis. Poster presented at the 20th ICPE International Conference on Pharmacoepidemiology & Therapeutic Risk Management; August 22, 2004. Bordeaux.

Eaton SC, Andrews EB, Hollis KA, Hopkins JS, Ameen VZ, Hamm L, Mangel AW, Williams RL, Cook SF. Prevalence and demographics of ibs respondents: results from a large web-based survey. Poster presented at the 20th ICPE International Conference on Pharmacoepidemiology & Therapeutic Risk Management; August 22, 2004. Bordeaux.